Can-Fite BioPharma Ltd. Capital Expenditures
Can-Fite BioPharma Ltd. (CANF) reported Capital Expenditures of $2.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-03-26
| Period end | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|
| 2025-12-31 | $2.00K 20-F · filed 2026-03-26 | |
| 2025-06-30 | $1.00K 6-K · filed 2025-08-28 | |
| 2024-12-31 | $5.00K 20-F · filed 2026-03-26 | |
| 2024-06-30 | $4.00K 6-K · filed 2025-08-28 | |
| 2023-12-31 | $2.00K 20-F · filed 2026-03-26 | |
| 2023-06-30 | $2.00K 6-K · filed 2024-08-29 | |
| 2022-12-31 | $9.00K 20-F · filed 2025-04-14 | |
| 2022-06-30 | $5.00K 6-K · filed 2023-08-31 | |
| 2021-12-31 | $11.00K 20-F · filed 2024-03-28 | |
| 2021-06-30 | $8.00K 6-K · filed 2022-08-25 | |
| 2020-12-31 | $26.00K 20-F · filed 2023-03-30 | |
| 2019-12-31 | $3.00K 20-F · filed 2022-03-24 | |
| 2019-06-30 | $1.00K 6-K · filed 2020-08-27 | |
| 2018-12-31 | $33.00K 20-F · filed 2021-03-25 | |
| 2017-12-31 | $7.00K 6-K · filed 2020-06-01 |